Mice deficient in Msh2 most commonly develop early-onset thymic lymphomas although other tumors including small intestinal tumors occur with a lower frequency at later stage [18,19], this may be analog to the early-onset childhood T-cell malignancies in humans with biallelic MSH2 mutations [12]. Here, MSH2 is linked to small intestine neoplasm.